Iksuda Therapeutics’ Post

Another exciting announcement from the Iksuda team! 👇 Iksuda presents encouraging IKS014 Phase 1 data at ESMO Read all about it here https://lnkd.in/gfzQ3JSM #ESMO2025

Charles Scheyd

Chief Executive at FJS Consultants Limited

1d

Great stuff guys!!

To view or add a comment, sign in

Explore content categories